By Dave Sebastian

Becton Dickinson & Co. said its profit and revenue rose for the fiscal third quarter as healthcare utilization levels continued to recover from the initial effects of the Covid-19 pandemic.

The Franklin Lakes, N.J.-based medical-technology company on Thursday posted net income of $525 million, compared with $286 million a year earlier. Earnings were $1.72 a share, compared with 97 cents a share.

Adjusted earnings were $2.74 a share. Analysis polled by FactSet were expecting $2.45 a share.

Revenue rose 26.9% to $4.89 billion, the company said. Analysts were looking for $4.51 billion.

Covid-19 testing revenue was $300 million, including BD Veritor Plus System revenue of $212 million, the company said.

Write to Dave Sebastian at dave.sebastian@wsj.com

(END) Dow Jones Newswires

August 05, 2021 06:30 ET (10:30 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Becton Dickinson Charts.
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Becton Dickinson Charts.